Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm

Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of antimicrobial agents 2011-04, Vol.37 (4), p.324-331
Hauptverfasser: Rivardo, Fabrizio, Martinotti, Maria Giovanna, Turner, Raymond Joseph, Ceri, Howard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 331
container_issue 4
container_start_page 324
container_title International journal of antimicrobial agents
container_volume 37
creator Rivardo, Fabrizio
Martinotti, Maria Giovanna
Turner, Raymond Joseph
Ceri, Howard
description Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.
doi_str_mv 10.1016/j.ijantimicag.2010.12.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_858285873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0924857911000197</els_id><sourcerecordid>858285873</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhiMEotvCX4BwQD1l8dhxYl-QqlULSJU4bHu2HGeyO0u-sBPQ_nscdvkQJ062rOedef3OJMkbYGtgULw7rOlg-4k6cna35mx552sG8CRZgSp5VmoQT5MV0zzPlCz1RXIZwoExkCKXz5MLDgIK0OUq2W-PPfodhYlcik2DbkqHJm1pHEYcJ6oxrWgIs2-sm2LP9DtN-3RpHp-jJqR2Z6kPU3ob3B49uT3Z1A0tpZu7B1aKRd5Q271InjW2DfjyfF4lj3e3D5uP2f3nD582N_eZy5WcsjL6crqpFVcKKlsxbZUtZCnyiiMHWyGUkqMt4h2twKLSosyhzquaQyWEuEquT3VHP3ydMUymo-CwbW2PwxyMkrG0VOVC6hPp_BCCx8aMnjrrjwaYWXI2B_NXzmbJ2QA3MeeofXXuMlcd1r-Vv4KNwNszYIOzbeNt7yj84YRWgkkdudcnrrGDsTsfmcdt7CTjsBQXP21uTgTG1L4RehMcYe-wJh-nZeqB_svw-3-quJb6iLVf8IjhMMy-j2MxYEIUmO2yOsvmALDoJH7oB17qwGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>858285873</pqid></control><display><type>article</type><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</creator><creatorcontrib>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</creatorcontrib><description>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</description><identifier>ISSN: 0924-8579</identifier><identifier>EISSN: 1872-7913</identifier><identifier>DOI: 10.1016/j.ijantimicag.2010.12.011</identifier><identifier>PMID: 21316197</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Anti-Bacterial Agents - pharmacology ; anti-infective properties ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacillus licheniformis ; Biofilm ; Biofilms ; Biological and medical sciences ; Biosurfactant ; biosurfactants ; catheters ; cefazolin ; ceftriaxone ; ciprofloxacin ; Eradication ; Escherichia coli ; Escherichia coli - drug effects ; Infectious Disease ; Lipopeptide ; lipopeptides ; Lipopeptides - pharmacology ; Medical sciences ; Microbial Sensitivity Tests ; microorganisms ; Microscopy, Confocal ; pathogens ; Pharmacology. Drug treatments ; piperacillin ; polystyrenes ; sulfamethoxazole ; Surface-Active Agents - pharmacology ; synergism ; Synergy ; tobramycin ; trimethoprim ; Uropathogenic Escherichia coli</subject><ispartof>International journal of antimicrobial agents, 2011-04, Vol.37 (4), p.324-331</ispartof><rights>Elsevier B.V. and the International Society of Chemotherapy</rights><rights>2011 Elsevier B.V. and the International Society of Chemotherapy</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</citedby><cites>FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0924857911000197$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23983059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21316197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivardo, Fabrizio</creatorcontrib><creatorcontrib>Martinotti, Maria Giovanna</creatorcontrib><creatorcontrib>Turner, Raymond Joseph</creatorcontrib><creatorcontrib>Ceri, Howard</creatorcontrib><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><title>International journal of antimicrobial agents</title><addtitle>Int J Antimicrob Agents</addtitle><description>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>anti-infective properties</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacillus licheniformis</subject><subject>Biofilm</subject><subject>Biofilms</subject><subject>Biological and medical sciences</subject><subject>Biosurfactant</subject><subject>biosurfactants</subject><subject>catheters</subject><subject>cefazolin</subject><subject>ceftriaxone</subject><subject>ciprofloxacin</subject><subject>Eradication</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Infectious Disease</subject><subject>Lipopeptide</subject><subject>lipopeptides</subject><subject>Lipopeptides - pharmacology</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>microorganisms</subject><subject>Microscopy, Confocal</subject><subject>pathogens</subject><subject>Pharmacology. Drug treatments</subject><subject>piperacillin</subject><subject>polystyrenes</subject><subject>sulfamethoxazole</subject><subject>Surface-Active Agents - pharmacology</subject><subject>synergism</subject><subject>Synergy</subject><subject>tobramycin</subject><subject>trimethoprim</subject><subject>Uropathogenic Escherichia coli</subject><issn>0924-8579</issn><issn>1872-7913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk1v1DAQhiMEotvCX4BwQD1l8dhxYl-QqlULSJU4bHu2HGeyO0u-sBPQ_nscdvkQJ062rOedef3OJMkbYGtgULw7rOlg-4k6cna35mx552sG8CRZgSp5VmoQT5MV0zzPlCz1RXIZwoExkCKXz5MLDgIK0OUq2W-PPfodhYlcik2DbkqHJm1pHEYcJ6oxrWgIs2-sm2LP9DtN-3RpHp-jJqR2Z6kPU3ob3B49uT3Z1A0tpZu7B1aKRd5Q271InjW2DfjyfF4lj3e3D5uP2f3nD582N_eZy5WcsjL6crqpFVcKKlsxbZUtZCnyiiMHWyGUkqMt4h2twKLSosyhzquaQyWEuEquT3VHP3ydMUymo-CwbW2PwxyMkrG0VOVC6hPp_BCCx8aMnjrrjwaYWXI2B_NXzmbJ2QA3MeeofXXuMlcd1r-Vv4KNwNszYIOzbeNt7yj84YRWgkkdudcnrrGDsTsfmcdt7CTjsBQXP21uTgTG1L4RehMcYe-wJh-nZeqB_svw-3-quJb6iLVf8IjhMMy-j2MxYEIUmO2yOsvmALDoJH7oB17qwGQ</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Rivardo, Fabrizio</creator><creator>Martinotti, Maria Giovanna</creator><creator>Turner, Raymond Joseph</creator><creator>Ceri, Howard</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110401</creationdate><title>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</title><author>Rivardo, Fabrizio ; Martinotti, Maria Giovanna ; Turner, Raymond Joseph ; Ceri, Howard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-7161c9fd82881bab09a8a65734b2e21abe1752ea621aea3e6b93741d4bd21b333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>anti-infective properties</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacillus licheniformis</topic><topic>Biofilm</topic><topic>Biofilms</topic><topic>Biological and medical sciences</topic><topic>Biosurfactant</topic><topic>biosurfactants</topic><topic>catheters</topic><topic>cefazolin</topic><topic>ceftriaxone</topic><topic>ciprofloxacin</topic><topic>Eradication</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Infectious Disease</topic><topic>Lipopeptide</topic><topic>lipopeptides</topic><topic>Lipopeptides - pharmacology</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>microorganisms</topic><topic>Microscopy, Confocal</topic><topic>pathogens</topic><topic>Pharmacology. Drug treatments</topic><topic>piperacillin</topic><topic>polystyrenes</topic><topic>sulfamethoxazole</topic><topic>Surface-Active Agents - pharmacology</topic><topic>synergism</topic><topic>Synergy</topic><topic>tobramycin</topic><topic>trimethoprim</topic><topic>Uropathogenic Escherichia coli</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivardo, Fabrizio</creatorcontrib><creatorcontrib>Martinotti, Maria Giovanna</creatorcontrib><creatorcontrib>Turner, Raymond Joseph</creatorcontrib><creatorcontrib>Ceri, Howard</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of antimicrobial agents</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivardo, Fabrizio</au><au>Martinotti, Maria Giovanna</au><au>Turner, Raymond Joseph</au><au>Ceri, Howard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm</atitle><jtitle>International journal of antimicrobial agents</jtitle><addtitle>Int J Antimicrob Agents</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>37</volume><issue>4</issue><spage>324</spage><epage>331</epage><pages>324-331</pages><issn>0924-8579</issn><eissn>1872-7913</eissn><abstract>Abstract Biofilms are microcolonies of microbes adherent to biotic and abiotic surfaces, often responsible for chronic infections and medical device contamination. Escherichia coli is one of the prevalent pathogens involved in uropathogenic infections and contamination of catheters. A biosurfactant produced by Bacillus licheniformis V9T14 was tested alone and in association with various antibiotics against a mature 24-h uropathogenic E. coli CFT073 biofilm. Biofilm was grown on polystyrene pegs of a Calgary Biofilm Device, providing a tool to evaluate the efficacy of antimicrobial agents. Antibiotics tested were ampicillin, cefazolin, ceftriaxone, ciprofloxacin, piperacillin, tobramycin and trimethoprim/sulfamethoxazole (19:1). Biosurfactant alone at the concentrations tested was not able to remove the adherent cells of the pre-formed biofilm. However, the difference between the effect of antibiotic alone and in combination with the biosurfactant was significant and exceeded 1 log10 (90%) reduction in most cases. Results of this study indicate that V9T14 biosurfactant in association with antibiotics leads to a synergistic increase in the efficacy of antibiotics in biofilm killing, and in some combinations leads to total eradication of E. coli CFT073 biofilm.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>21316197</pmid><doi>10.1016/j.ijantimicag.2010.12.011</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-8579
ispartof International journal of antimicrobial agents, 2011-04, Vol.37 (4), p.324-331
issn 0924-8579
1872-7913
language eng
recordid cdi_proquest_miscellaneous_858285873
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-Bacterial Agents - pharmacology
anti-infective properties
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacillus licheniformis
Biofilm
Biofilms
Biological and medical sciences
Biosurfactant
biosurfactants
catheters
cefazolin
ceftriaxone
ciprofloxacin
Eradication
Escherichia coli
Escherichia coli - drug effects
Infectious Disease
Lipopeptide
lipopeptides
Lipopeptides - pharmacology
Medical sciences
Microbial Sensitivity Tests
microorganisms
Microscopy, Confocal
pathogens
Pharmacology. Drug treatments
piperacillin
polystyrenes
sulfamethoxazole
Surface-Active Agents - pharmacology
synergism
Synergy
tobramycin
trimethoprim
Uropathogenic Escherichia coli
title Synergistic effect of lipopeptide biosurfactant with antibiotics against Escherichia coli CFT073 biofilm
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A59%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20effect%20of%20lipopeptide%20biosurfactant%20with%20antibiotics%20against%20Escherichia%20coli%20CFT073%20biofilm&rft.jtitle=International%20journal%20of%20antimicrobial%20agents&rft.au=Rivardo,%20Fabrizio&rft.date=2011-04-01&rft.volume=37&rft.issue=4&rft.spage=324&rft.epage=331&rft.pages=324-331&rft.issn=0924-8579&rft.eissn=1872-7913&rft_id=info:doi/10.1016/j.ijantimicag.2010.12.011&rft_dat=%3Cproquest_cross%3E858285873%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=858285873&rft_id=info:pmid/21316197&rft_els_id=1_s2_0_S0924857911000197&rfr_iscdi=true